Asia-Pacific Artificial Tear Market Reaches $906.9 Million in 2025 with 6.2% CAGR

Asia-Pacific artificial tear market was valued at $906.9 million in 2025 and is projected to reach $1,639.5 million by 2035, growing at a CAGR of 6.2% during the forecast period (2026–2035). Market growth is driven by the rising prevalence of dry eye disease across both developed and emerging economies, increasing screen time associated with digitalization and remote work, and a rapidly aging population prone to ocular surface disorders. The region is witnessing growing awareness of eye health, supported by expanding access to ophthalmic care, rising disposable incomes, and strong demand for over-the-counter artificial tear products. Countries such as China, Japan, India, South Korea, and Australia are key contributors, benefiting from large patient populations, improving healthcare infrastructure, and increasing adoption of preservative-free and long-acting lubricating eye solutions.

Browse the full report description of “Asia-Pacific Artificial Tear Market Size, Share & Trends Analysis Report by Type (Cellulose-Derived Tears, Glycerin-Derived Tears, Oil-Based Emulsion Tears, and Polyethylene Glycol- & Propylene Glycol-Based Tears), By Delivery Method (Eyedrops and Ointments/Gel), By Application (Dry Type Treatment, Contact Lens Moisture, and Digital Eye Strain) and By End-User (Retail Pharmacies (OTC), Online Pharmacies, Hospitals & Ophthalmic Clinics, and Other End User) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/asia-pacific-artificial-tears-market

Key trends shaping the Asia-Pacific market include the development of advanced formulations with enhanced hydration and longer retention time, growing preference for preservative-free multi-dose packaging, and increased product availability through retail pharmacies, hospital channels, and e-commerce platforms.

According to PMC and regional epidemiological studies, dry eye disease (DED) is highly prevalent across Asia-Pacific populations, contributing to increasing reliance on artificial tears and ocular lubricants in clinics, pharmacies, and consumer care settings throughout the region.

Key Innovators Driving Asia-Pacific Artificial Tear Transformation

The key players in the Asia-Pacific artificial tear market include AbbVie Inc., Alcon Inc., Bausch +?Lomb Corporation, Johnson & Johnson Vision Care, Santen Pharmaceutical Co., Ltd. These companies are focused on innovation in preservative-free technologies, long-lasting lubrication, and patient-friendly delivery formats to address diverse dry eye severity levels and improve treatment adherence.

• In January 2025, Santen Pharmaceutical launched a new preservative-free artificial tear formulation in China aimed at patients with moderate to severe dry eye. The launch reflects rising demand for safer, irritation-free therapies and strengthens the company’s presence in leading ophthalmology clinics across the country.
• In April 2024, Allergan expanded its Asia–Pacific footprint by introducing advanced cellulose-derived and multipurpose eye drops in markets including India, South Korea, and Japan. This expansion highlights growing adoption of innovative formulations tailored to regional ocular health requirements.
• In October 2024, Rohto Pharmaceutical of Japan introduced a single-use, fast-acting artificial tear product featuring enhanced hydration technology, specifically targeting digital-device users. The launch underscores continued innovation in delivery formats and patient-centric product design within the APAC market.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Type
  • Delivery Method
  • By Application
  • By End-User
• Competitive Landscape - AbbVie Inc., Alcon Inc., Bausch +?Lomb Corporation, Johnson & Johnson Vision Care, Santen Pharmaceutical Co., Ltd.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Asia-Pacific Artificial Tear Market Report Segment

By Type

• Cellulose-Derived Tears
• Glycerin-Derived Tears
• Oil-Based Emulsion Tears
• Polyethylene Glycol- & Propylene Glycol-Based Tears

By Delivery Method

• Eyedrops
• Ointments/Gel

By Application

• Dry Type Treatment
• Contact Lens Moisture
• Digital Eye Strain

By End-User

• Retail Pharmacies (OTC)
• Online Pharmacies
• Hospitals & Ophthalmic Clinics
• Other End User

Asia-Pacific Artificial Tear Market Report Segment by Country

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-artificial-tears-market